attraction-3: nivolumab versus chemotherapy in advanced oesophageal squamous cell carcinoma
Published 4 years ago • 1.2K plays • Length 3:13Download video MP4
Download video MP3
Similar videos
-
5:20
nivolumab vs chemotherapy for advanced esophageal squamous cell carcinoma
-
9:32
checkmate 648: nivolumab plus ipilimumab or nivo plus chemo versus chemo as (1l) treatment for a...
-
8:16
nivolumab for oesophageal cancer following chemoradiation therapy
-
2:47
attraction-4: nivolumab plus chemotherapy for gastric or gastroesophageal cancer
-
11:12
expert video report on immunotherapy in gastro oesophageal cancer from 2021 asco annual meeting
-
1:22
3-year follow-up of checkmate 649: nivolumab chemotherapy in gc/gejc/eac
-
1:01
long-term efficacy of nivolumab combinations in advanced escc in checkmate 648
-
7:12
part 2 - nivolumab with chemotherapy in advanced previously untreated gastric - dr. anant ramaswamy
-
13:56
emerging data with immunotherapy in esophageal squamous cell carcinoma
-
3:01
treating patients with gastric cancer with immunotherapy: who will benefit?
-
13:47
checkmate 577 - is nivolumab adjuvant the standard of care in esophagus and gej?
-
9:10
adjuvant nivolumab in resected oesophageal or goj cancer following chemo
-
6:31
fda d.i.s.c.o. burst edition: fda approvals of opdivo in combination with chemotherapy and opdivo...
-
2:04
rime: nivolumab, rucaparib and ramucirumab in advanced gastroesophageal cancer
-
6:31
checkmate 649 biomarker analyses of nivo ipi vs chemo for patients with gc/gejc/eac
-
1:19
29-month follow-up from checkmate 648: nivolumab combination therapy in escc
-
8:45
keynote-590: pembrolizumab plus chemotherapy for advanced oesophageal cancer
-
4:47
nivolumab chemotherapy combination treatment: checkmate649 and attraction-4
-
1:44
checkmate 649: nivolumab and chemotherapy or ipilimumab in gc/gejc/eac
-
8:38
checkmate 459: nivolumab plus chemotherapy for gc / gejc / eac
-
3:49
nivolumab alone versus nivolumab plus ipilimumab in patients with resectable hcc
-
0:55
dr. cohen on immunotherapy in head and neck squamous cell carcinoma